Valenta et al., 2009 - Google Patents
From allergen genes to allergy vaccinesValenta et al., 2009
View PDF- Document ID
- 6241947424553333742
- Author
- Valenta R
- Ferreira F
- Focke-Tejkl M
- Linhart B
- Niederberger V
- Swoboda I
- Vrtala S
- Publication year
- Publication venue
- Annual review of immunology
External Links
Snippet
IgE-mediated allergy is a hypersensitivity disease affecting more than 25% of the population. The structures of the most common allergens have been revealed through molecular cloning technology in the past two decades. On the basis of this knowledge of the sequences and …
- 230000002009 allergen 0 title abstract description 436
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valenta et al. | From allergen genes to allergy vaccines | |
| Valenta et al. | From allergen structure to new forms of allergen-specific immunotherapy | |
| Zhernov et al. | Recombinant allergens for immunotherapy: state of the art | |
| Dorofeeva et al. | Past, present, and future of allergen immunotherapy vaccines | |
| Valenta et al. | Recombinant allergens | |
| Valenta et al. | Recombinant allergens for allergen‐specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens | |
| Valenta et al. | Recombinant allergens for diagnosis and therapy of allergic diseases | |
| Valenta et al. | Allergen‐specific immunotherapy: from therapeutic vaccines to prophylactic approaches | |
| Tscheppe et al. | Recombinant allergens in structural biology, diagnosis, and immunotherapy | |
| Moingeon et al. | Immune mechanisms of allergen‐specific sublingual immunotherapy | |
| CN103272227B (en) | Peptides for desensibilization against allergens | |
| Linhart et al. | Vaccines for allergy | |
| Jutel et al. | Recombinant allergens: the present and the future | |
| Ferreira et al. | Molecular approach to allergy diagnosis and therapy | |
| Linhart et al. | Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy | |
| CN102307893B (en) | Peptides for vaccine | |
| Palomares et al. | The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases | |
| Wiedermann et al. | Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice | |
| Wallner et al. | Recombinant allergens for pollen immunotherapy | |
| Niederberger et al. | Molecular approaches for new vaccines against allergy | |
| US20090130130A1 (en) | Mutant allergen(s) | |
| Rossi et al. | Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)-specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients | |
| Edlmayr et al. | Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases | |
| Niederberger et al. | Recombinant allergens for immunotherapy. Where do we stand? | |
| Grönlund et al. | Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen |